Patents by Inventor Katharina Beller

Katharina Beller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10634588
    Abstract: The present invention relates to a reagent for the disruption of cell material, containing an internal standard that is completely integrated into the reagent for control and evaluation of the completeness of disruption of the cell material and subsequent steps, comprising a step selected from sample preparation, extraction, enrichment, isolation, purification, reverse transcription, amplification and detection of the cell components obtained from the disrupted cells, or a combination of a plurality or all of these steps.
    Type: Grant
    Filed: September 23, 2011
    Date of Patent: April 28, 2020
    Assignee: QIAGEN GmbH
    Inventors: Dirk Heckel, Katharina Beller
  • Patent number: 10221445
    Abstract: The present invention refers to a method, a composition and a kit for isolating biomolecules from any biological sample material containing cells, virus(es), microorganism(s) or a combination thereof comprising a cell- or virus-simulating means, wherein said cell- or virus-simulating means comprises at least one type of marker molecule(s), incorporated in at least one type of a layer, capsule, bead, sphere or particle, which is not a biological cell or provided on a substrate covered by a coating.
    Type: Grant
    Filed: August 13, 2012
    Date of Patent: March 5, 2019
    Assignees: QIAGEN GmbH, QIAGEN Hamburg GmbH
    Inventors: Katharina Beller, Thomas Doedt, Dirk Heckel, Rainer Söller
  • Publication number: 20140248606
    Abstract: The present invention refers to a method, a composition and a kit for isolating biomolecules from any biological sample material containing cells, virus(es), microorganism(s) or a combination thereof comprising a cell- or virus-simulating means, wherein said cell- or virus-simulating means comprises at least one type of marker molecule(s), incorporated in at least one type of a layer, capsule, bead, sphere or particle, which is not a biological cell or provided on a substrate covered by a coating.
    Type: Application
    Filed: August 13, 2012
    Publication date: September 4, 2014
    Applicants: QIAGEN HAMBURG GMBH, QIAGEN GMBH
    Inventors: Katharina Beller, Thomas Doedt, Dirk Heckel, Rainer Söller
  • Publication number: 20130236900
    Abstract: The present invention relates to a reagent for the disruption of cell material, containing an internal standard that is completely integrated into the reagent for control and evaluation of the completeness of disruption of the cell material and subsequent steps, comprising a step selected from sample preparation, extraction, enrichment, isolation, purification, reverse transcription, amplification and detection of the cell components obtained from the disrupted cells, or a combination of a plurality or all of these steps.
    Type: Application
    Filed: September 23, 2011
    Publication date: September 12, 2013
    Applicant: QIAGEN GMBH
    Inventors: Dirk Heckel, Katharina Beller